Fasting glucose — the morning number that signals more than diabetes

Paired condition: Prediabetes lab results

Quick answer

Fasting glucose is your blood sugar after an overnight fast (typically 8+ hours). It's a snapshot of how well your body manages glucose at rest. Standard cutoffs: < 100 mg/dL normal, 100 – 125 prediabetic, ≥ 126 diabetic on two separate occasions. But the *single number* tells you less than how it pairs with fasting insulin — which is the upstream signal of insulin resistance, often years ahead of glucose movement.

Reference ranges and interpretation

Value / populationClassificationWhat it means
< 70 mg/dLHypoglycemiaBelow normal; investigate medication, insulinoma, reactive hypoglycemia, or measurement artifact.
70 – 99NormalStandard reference range.
85 – 99Optimal upper edgeSome longevity-oriented practitioners target < 90; > 90 with elevated insulin is an early metabolic signal.
100 – 125Impaired fasting glucose / prediabetesThe intervention window. Most reversible territory in chronic disease.
≥ 126Diabetes (on two separate occasions)Diagnostic.

Fasting glucose can vary 5–10 mg/dL day to day in the same person based on sleep, recent stress, time of last meal, and pre-draw activity. A single elevated value warrants confirmation.

What different values typically indicate

70 – 85 mg/dL: generally reassuring. Excellent fasting metabolism. Worth confirming the rest of the panel matches (fasting insulin, lipid markers) — extremely low fasting glucose with high fasting insulin is rare but indicates ongoing insulin oversecretion.
85 – 99 mg/dL: "normal" but increasingly worth context. With fasting insulin < 8, this is healthy. With fasting insulin > 12, the pancreas is working hard to keep glucose in range — that's a setup for the future.
100 – 110 mg/dL: early impaired fasting glucose. Almost always paired with elevated fasting insulin and rising HbA1c trajectory. The most reversible window in chronic disease — targeted lifestyle change typically pulls this back into normal range within 3 months.
110 – 125 mg/dL: later prediabetic territory. Often paired with worsening lipid panel (triglycerides up, HDL down) and visible signs of insulin resistance (abdominal weight, energy patterns). Still highly reversible but the work is bigger.
≥ 126 mg/dL: diabetes by US criteria. Confirmation on a separate day is needed. From here, the conversation shifts to active management (lifestyle, possibly medication, regular monitoring).

What to look at alongside fasting glucose

Fasting glucose alone is a snapshot. The story includes:
- Fasting insulin — the engine behind the glucose number
- HOMA-IR — calculated insulin resistance from fasting glucose × insulin
- HbA1c — the 3-month average for trajectory
- Triglycerides + HDL ratio — lipid markers of insulin resistance
- Post-meal glucose response — captured best with a CGM trial or an OGTT (oral glucose tolerance test)
- Sleep, stress, alcohol patterns — all acutely shift fasting glucose
A fasting glucose of 96 with fasting insulin of 22 is much more concerning than a fasting glucose of 110 with fasting insulin of 5.

Caveats that distort fasting glucose

- Acute stress or illness — cortisol and stress hormones raise fasting glucose acutely
- Poor sleep the night before — one night of partial sleep deprivation can raise fasting glucose 5–10 mg/dL
- Late-evening eating — meals close to bedtime push fasting glucose up
- Alcohol the night before — can either elevate or lower depending on quantity and timing
- Steroid medications — corticosteroids elevate fasting glucose, sometimes substantially
- Recent strenuous exercise — can transiently raise glucose; can also lower it the morning after
A single high reading taken under any of these conditions should be repeated under standardized conditions before drawing conclusions.

Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.

Start with my labs →

Frequently asked questions

Do I really need to fast 8 hours, or is 6 hours OK?

Most labs and guidelines require 8+ hours for "fasting" glucose. Shorter fasts may yield slightly higher values that don't compare cleanly against fasting reference ranges. Water is OK; coffee with anything (even cream) is not.

Why is my fasting glucose higher in the morning than my CGM showed overnight?

The "dawn phenomenon" — a normal cortisol-driven glucose rise in early morning — can push the standard draw-time fasting glucose higher than the lowest overnight reading. This is physiologic, not necessarily pathologic, but the pattern is worth tracking if you have access to CGM data.

My fasting glucose is fine but my HbA1c is borderline. What does that mean?

You may have meaningful post-meal glucose spikes that drive up the 3-month average without elevating the fasting value. A CGM trial or oral glucose tolerance test will reveal it. This is a common pattern in early insulin resistance.

Is 99 mg/dL really different from 100 mg/dL?

Statistically, no — within normal measurement variability. Categorically, 100 crosses the prediabetes threshold and triggers a different clinical framing. The number is one input; the full panel is the picture.

Can I lower fasting glucose quickly?

Yes — many people see meaningful drops within 4–8 weeks of: walking 10–20 minutes after evening meal, prioritizing 7+ hours sleep, reducing late-night eating, adding resistance training, and prioritizing protein over refined carbohydrates at breakfast.

References

All citations verified against PubMed / publisher of record 2026-05-26.

  1. 1.American Diabetes Association Professional Practice Committee. (2024). Standards of Care in Diabetes—2024. Diabetes Care. 47(Suppl 1):S1-S321.Source for fasting glucose diagnostic thresholds (< 100 normal, 100–125 impaired fasting glucose, ≥ 126 diabetes).DOI →
  2. 2.Knowler WC, Barrett-Connor E, Fowler SE, et al. (Diabetes Prevention Program Research Group). (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 346(6):393-403.DPP: lifestyle intervention reduced T2D incidence; basis for reversal-trajectory framing.PubMed →DOI →
  3. 3.Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7):412-419.Original HOMA-IR derivation; fasting glucose × fasting insulin → HOMA-IR.PubMed →DOI →
  4. 4.Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. (2012). Prediabetes: a high-risk state for diabetes development. Lancet. 379(9833):2279-2290.Trajectory of fasting glucose rise pre-diabetes.PubMed →DOI →
  5. 5.Battelino T, Danne T, Bergenstal RM, et al. (2019). Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 42(8):1593-1603.Reference data on post-meal glucose response and CGM-based glucose targets.PubMed →DOI →

Functional / longevity-medicine targets (e.g., fasting glucose < 90 mg/dL with fasting insulin < 8) reflect practice positions rather than ADA guideline cutoffs. Every link above opens the PubMed abstract or publisher's DOI landing page in a new tab. All citations verified vs PubMed / publisher of record 2026-05-26.

By Steve Pinedo

Co-founder, Phi Longevity

Last updated: 2026-05-26

Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →

Related